1. Home
  2. NLSP vs MTA Comparison

NLSP vs MTA Comparison

Compare NLSP & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • MTA
  • Stock Information
  • Founded
  • NLSP 2015
  • MTA 1983
  • Country
  • NLSP Switzerland
  • MTA Canada
  • Employees
  • NLSP N/A
  • MTA N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • MTA
  • Sector
  • NLSP Health Care
  • MTA
  • Exchange
  • NLSP Nasdaq
  • MTA Nasdaq
  • Market Cap
  • NLSP 243.8M
  • MTA 237.9M
  • IPO Year
  • NLSP 2021
  • MTA N/A
  • Fundamental
  • Price
  • NLSP $4.90
  • MTA $3.28
  • Analyst Decision
  • NLSP
  • MTA
  • Analyst Count
  • NLSP 0
  • MTA 0
  • Target Price
  • NLSP N/A
  • MTA N/A
  • AVG Volume (30 Days)
  • NLSP 26.6K
  • MTA 332.3K
  • Earning Date
  • NLSP 10-11-2024
  • MTA 11-08-2024
  • Dividend Yield
  • NLSP N/A
  • MTA 0.70%
  • EPS Growth
  • NLSP N/A
  • MTA N/A
  • EPS
  • NLSP N/A
  • MTA N/A
  • Revenue
  • NLSP N/A
  • MTA $4,785,000.00
  • Revenue This Year
  • NLSP N/A
  • MTA $44.55
  • Revenue Next Year
  • NLSP N/A
  • MTA $149.35
  • P/E Ratio
  • NLSP N/A
  • MTA N/A
  • Revenue Growth
  • NLSP N/A
  • MTA 48.42
  • 52 Week Low
  • NLSP $4.08
  • MTA $2.32
  • 52 Week High
  • NLSP $40.60
  • MTA $3.65
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 37.46
  • MTA 57.54
  • Support Level
  • NLSP $4.72
  • MTA $3.18
  • Resistance Level
  • NLSP $5.50
  • MTA $3.36
  • Average True Range (ATR)
  • NLSP 0.65
  • MTA 0.13
  • MACD
  • NLSP 0.02
  • MTA -0.01
  • Stochastic Oscillator
  • NLSP 28.47
  • MTA 64.79

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

Share on Social Networks: